Zheng Zha
Overview
Explore the profile of Zheng Zha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu S, Zha Z, Li C, Li C, Wang L
J Ethnopharmacol
. 2024 Dec;
340():119283.
PMID: 39733800
Ethnopharmacological Relevance: The Bu Shen Yi Sui capsule (BSYS), a modified version of the classical Chinese medicine formula Liu Wei Di Huang pill, has demonstrated therapeutic efficacy in the treatment...
2.
Wu J, Yang J, Hu J, Xu S, Zhang X, Qian S, et al.
Front Immunol
. 2024 Sep;
15:1429895.
PMID: 39229262
Background: Multiple sclerosis (MS) is the most common non-traumatic disabling disease affecting young adults. A definitive curative treatment is currently unavailable. Many randomized controlled trials (RCTs) have reported the efficacy...
3.
Plotnik J, Zha Z, Feng W, Lee I, Riehm J, McClure R, et al.
Mol Cancer Res
. 2024 May;
22(8):689-698.
PMID: 38747975
Small-cell lung cancer (SCLC) accounts for nearly 15% of all lung cancers. Although patients respond to first-line therapy readily, rapid relapse is inevitable, with few treatment options in the second-line...
4.
Zha Z, Liu Y, Liu S, Zhang N, Li J, Qi F, et al.
Oxid Med Cell Longev
. 2022 Sep;
2022:3800004.
PMID: 36092158
. Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system (CNS) primarily hallmarked by neuroinflammation and demyelination. The activation of astrocytes exerts double-edged sword effects, which...
5.
Zha Z, Liu S, Liu Y, Li C, Wang L
Antioxidants (Basel)
. 2022 Aug;
11(8).
PMID: 36009214
Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central nervous system (CNS) characterized by immune cell infiltration, demyelination and axonal injury. Oxidative stress-induced inflammatory response, especially the destructive...
6.
Zha Z, Liu Y, Liu S, Zhang N, Li J, Qi F, et al.
Mediators Inflamm
. 2022 Jul;
2022:9241261.
PMID: 35865997
Methods: The potential active ingredients and corresponding potential targets of BSYS Capsule were obtained from the TCMSP, BATMAN-TCM, Swiss Target Prediction platform, and literature research. Disease targets of CNSD were...
7.
Ji J, Sun Y, Zha Z, Xue B, Li J, Jin L, et al.
Evid Based Complement Alternat Med
. 2022 Apr;
2022:3341481.
PMID: 35463062
Remyelination is a refractory feature of demyelinating diseases such as multiple sclerosis (MS). Studies have shown that promoting oligodendrocyte precursor cell (OPC) differentiation, which cannot be achieved by currently available...
8.
Shao H, Xiao M, Zha Z, Olatunji O
Food Sci Nutr
. 2022 Apr;
10(4):1058-1069.
PMID: 35432973
Diabetes mellitus (DM) is a chronic disorder associated with severe metabolic derangement and comorbidities. The constant increase in the global population of diabetic patients coupled with some prevailing side effects...
9.
Zhang L, Cai T, Lin X, Huang X, Bui M, Plotnik J, et al.
Mol Cancer Ther
. 2021 Jul;
20(10):1809-1819.
PMID: 34253595
Dual bromodomain BET inhibitors that bind with similar affinities to the first and second bromodomains across BRD2, BRD3, BRD4, and BRDT have displayed modest activity as monotherapy in clinical trials....
10.
Yang T, Zha Z, Yang X, Kang Y, Wang X, Tong Y, et al.
Front Neurosci
. 2021 May;
15:663541.
PMID: 33981197
Favorable effects exerted by long-term administration of fingolimod therapy in multiple sclerosis (MS) patients have been reported, but sporadic side effects, such as reversible macular edema, also have been recorded....